| Title : Odanacatib, a selective cathepsin K inhibitor, demonstrates comparable pharmacodynamics and pharmacokinetics in older men and postmenopausal women - Anderson_2014_J.Clin.Endocrinol.Metab_99_552 |
| Author(s) : Anderson MS , Gendrano IN , Liu C , Jeffers S , Mahon C , Mehta A , Mostoller K , Zajic S , Morris D , Lee J , Stoch SA |
| Ref : J Clinical Endocrinology Metab , 99 :552 , 2014 |
| Abstract : Anderson_2014_J.Clin.Endocrinol.Metab_99_552 |
| ESTHER : Anderson_2014_J.Clin.Endocrinol.Metab_99_552 |
| PubMedSearch : Anderson_2014_J.Clin.Endocrinol.Metab_99_552 |
| PubMedID: 24276460 |
Anderson MS, Gendrano IN, Liu C, Jeffers S, Mahon C, Mehta A, Mostoller K, Zajic S, Morris D, Lee J, Stoch SA (2014)
Odanacatib, a selective cathepsin K inhibitor, demonstrates comparable pharmacodynamics and pharmacokinetics in older men and postmenopausal women
J Clinical Endocrinology Metab
99 :552
Anderson MS, Gendrano IN, Liu C, Jeffers S, Mahon C, Mehta A, Mostoller K, Zajic S, Morris D, Lee J, Stoch SA (2014)
J Clinical Endocrinology Metab
99 :552